As of Jul 31
| +0.03 / +1.16%|
The 3 analysts offering 12-month price forecasts for Accretive Health Inc have a median target of 3.00, with a high estimate of 9.00 and a low estimate of 2.70. The median estimate represents a +14.94% increase from the last price of 2.61.
The current consensus among 4 polled investment analysts is to Hold stock in Accretive Health Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.